| Mass Spectrometry-Based Metabolic Profiling of Urinary Metabolites of N′-Nitrosonornicotine (NNN) in the Rat Y Li, RP Dator, LA Maertens, S Balbo, SS Hecht Chemical research in toxicology 36 (5), 769-781, 2023 | | 2023 |
| Identification of formaldehyde-induced DNA–RNA cross-links in the A/J mouse lung tumorigenesis model RP Dator, KJ Murray, MW Luedtke, FC Jacobs, F Kassie, HD Nguyen, ... Chemical research in toxicology 35 (11), 2025-2036, 2022 | 11 | 2022 |
| Metabolomics profiles of smokers from two ethnic groups with differing lung cancer risk R Dator, PW Villalta, N Thomson, J Jensen, DK Hatsukami, I Stepanov, ... Chemical research in toxicology 33 (8), 2087-2098, 2020 | 17 | 2020 |
| Exploration of LC-MS approaches for DNA adductome mapping and modeling E Van de Walle, RP Dator, V Guidolin, M De Graeve, PW Villalta, ... Metabolomics 2020, 16th annual conference by Metabolomics Society, 2020 | | 2020 |
| Targeted High Resolution LC/MS3 Adductomics Method for the Characterization of Endogenous DNA Damage A Carrà, V Guidolin, RP Dator, P Upadhyaya, F Kassie, PW Villalta, ... Frontiers in chemistry 7, 658, 2019 | 34 | 2019 |
| High resolution mass spectrometry-based approaches for the investigation of chemical carcinogenesis S Balbo, R Dator, A Stornetta, V Guidolin, L Maertens, P Villalta ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019 | | 2019 |
| Bioanalytical and mass spectrometric methods for aldehyde profiling in biological fluids RP Dator, MJ Solivio, PW Villalta, S Balbo Toxics 7 (2), 32, 2019 | 45 | 2019 |
| Integrating multi-" omics"-mass spectrometry-based methods to characterize electronic cigarette exposure in humans R Dator, P Villalta, C Hooyman, L Maertens, S Balbo ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | 1 | 2018 |
| Identification of 4-(methylnitroamino)-1-(3-pyridyl-1-oxide)-1-butanone, a novel metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat urine L von Weymarn, R Dator, S Balbo, S Murphy ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | | 2018 |
| High-resolution/accurate mass DNA adductomics to screen for doxorubicin-induced adducts as biomarkers of therapeutic efficacy A Stornetta, K Walters, R Dator, V Guidolin, P Villalta, S Balbo ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | | 2018 |
| In vivo stable-isotope labeling and mass-spectrometry-based metabolic profiling of a potent tobacco-specific carcinogen in rats R Dator, LB von Weymarn, PW Villalta, CJ Hooyman, LA Maertens, ... Analytical chemistry 90 (20), 11863-11872, 2018 | 13 | 2018 |
| Mass Spectrometry-Based Metabolomics for the Investigation of Lung Cancer Susceptibility in Smokers from Two Ethnic Groups R Dator, PW Villalta, LA Maertens, JA Jensen, SE Murphy, I Stepanov, ... 66th ASMS Conference on Mass Spectrometry and Allied Topics, 2018 | | 2018 |
| An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression L Yang, T Stewart, M Shi, G Pottiez, R Dator, R Wu, P Aro, RJ Schuster, ... PROTEOMICS–Clinical Applications 11 (7-8), 1700045, 2017 | 15 | 2017 |
| P3. 01-052 DNA Adductomics to Identify the Role of Inflammation in NNK-Induced Lung Carcinogenesis S Balbo, A Carra', R Dator, F Kassie, P Villalta Journal of Thoracic Oncology 12 (1), S1151-S1152, 2017 | | 2017 |
| A High Resolution/Accurate Mass (HRAM) Data-Dependent MS3 Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl … R Dator, A Carrà, L Maertens, V Guidolin, PW Villalta, S Balbo Journal of The American Society for Mass Spectrometry 28 (4), 608-618, 2016 | 27 | 2016 |
| The aryl hydrocarbon receptor is a repressor of inflammation-associated colorectal tumorigenesis in mouse CJ Díaz-Díaz, SM Ronnekleiv-Kelly, M Nukaya, PG Geiger, S Balbo, ... Annals of surgery 264 (3), 429-436, 2016 | 96 | 2016 |
| Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery X Lin, M Shi, JG Masilamoni, R Dator, J Movius, P Aro, Y Smith, J Zhang Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1854 (7), 779-787, 2015 | 31 | 2015 |
| Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation*[S] M Shi, J Movius, R Dator, P Aro, Y Zhao, C Pan, X Lin, TK Bammler, ... Molecular & Cellular Proteomics 14 (3), 544-555, 2015 | 67 | 2015 |
| Targeted discovery and validation of plasma biomarkers of Parkinson’s disease C Pan, Y Zhou, R Dator, C Ginghina, Y Zhao, J Movius, E Peskind, ... Journal of proteome research 13 (11), 4535-4545, 2014 | 35 | 2014 |
| Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease M Shi, C Liu, TJ Cook, KM Bullock, Y Zhao, C Ginghina, Y Li, P Aro, ... Acta neuropathologica 128, 639-650, 2014 | 646 | 2014 |
